Quantcast

Latest B. Braun Medical Inc. Stories

2011-07-14 08:53:00

BETHLEHEM, Pa., July 14, 2011 /PRNewswire/ -- The Renal Therapies Division of B. Braun Medical Inc. (B. Braun) announced today the availability of the Plasmat(TM) Futura System for H.E.L.P.® LDL Apheresis therapy. This addition to B. Braun's existing H.E.L.P.® therapy provides a more easy-to-use system for clinicians to administer the most effective care to patients with severe hypercholesterolemia. (Logo:...

2011-07-12 11:09:00

BETHLEHEM, Pa., July 12, 2011 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun) announced today that it has acquired US patent 7,933,780, which was issued April 26, 2011, and two pending applications, providing the Company patent rights related to enhanced communication between medical devices and hospital information management systems through wireless communication. (Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO ) "The addition of this patent further broadens our existing...

2011-06-15 08:49:00

BETHLEHEM, Pa., June 15, 2011 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun) is part of one of the fastest growing medical technology corporations in the world -- it's also one of the Best Companies to Work For, according to Medical Device and Diagnostic Industry (MD+DI) magazine. One of just 10 medical device companies named to MD+DI's 2011 list, B. Braun "must be doing something right." (Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO ) In fact, B. Braun is doing many...

2011-06-13 17:22:00

BETHLEHEM, Pa. June 13, 2011 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today approved B. Braun Medical Inc.'s (B. Braun) application for 1g and 2g Ceftazidime for Injection USP and Dextrose Injection USP in the DUPLEX® Drug Delivery System. (Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO ) The availability of 1g and 2g Ceftazidime in the DUPLEX® System will mean faster, safer and accurate administration of Ceftazidime to...

2010-12-07 17:10:00

BETHLEHEM, Pa., Dec. 7, 2010 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun) has entered into a settlement agreement in the amount of $14.7 million with the Department of Justice to resolve a long-standing dispute relating to pricing information published by third parties for certain pharmaceutical products manufactured by B. Braun. The matter was part of an industry-wide investigation arising out of a qui tam action filed under seal in the Southern District of Florida in 1995 by...

2010-10-27 16:18:00

IRVINE, Calif., Oct. 27 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun) was recently notified by its supplier, Scientific Protein Laboratories LLC (SPL), of a nationwide recall of a lot of Heparin Sodium USP Active Pharmaceutical Ingredient (API) sold to B. Braun because additional testing of retained crude heparin samples used by SPL to manufacture this single API lot indicated a trace amount of oversulfated chondroitin sulfate (OSCS) contaminant. As a result, B. Braun is initiating a...

2010-10-20 09:38:00

BETHLEHEM, Pa. Oct. 20 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun) today announced its latest contract with Premier Purchasing Partners, the group purchasing unit of Premier, Inc., which will provide Premier's members - a network of approximately 2,400 U.S. hospitals and 70,000 other healthcare facilities - with the continued benefit of B. Braun's comprehensive portfolio of IV therapy products and solutions at specially terms. (Logo:...

2010-08-05 09:41:00

LOS ANGELES, Aug. 5 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun) "smart" pumps (www.smartpumps.bbraunusa.com/news) will become even smarter when customers gain premier access to customized, evidence-based drug libraries provided by the Zynx Health Device Network's Prime-A-Pump®, a web-based, customizable program for creating and updating drug libraries. (Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO) (Logo:...

2010-07-12 10:48:00

BETHLEHEM, Pa., July 12 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun) announced today the availability of large volume heparin infusion solutions. (Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ) Based on the new United States Pharmacopeia (USP) standards for heparin products released by the U.S. Food and Drug Administration (FDA) in October 2009, changes to B. Braun's large volume heparin IV solutions...

2010-06-02 11:33:00

BETHLEHEM, Pa., June 2 /PRNewswire/ -- B. Braun Medical Inc. announces the construction of a new infusion technology facility at the company's global headquarters in Melsungen, Germany. (Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ) Known as Avitum Village, the new, five-building, 77 million euro B. Braun manufacturing campus includes a plant dedicated to producing infusion pumps as well as facilities for research and development, services and training. With an initial...


Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related